A “Game of Thrones” in Metastatic Renal Cell Carcinoma: Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitors and Mammalian Target of Rapamycin Inhibitors Battling for Posi...

Por Pal, Sumanta Kumar, Vogelzang, Nicholas J.
Publicado em 2012

Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention

Por Moyad, Mark A, Vogelzang, Nicholas J
Publicado no Asian J Androl (2015)

Malignant mesothelioma advances in pathogenesis, diagnosis, and translational therapies /

Por Pass, Harvey I., Vogelzang, Nicholas J., Carbone, Michele.
Publicado em 2005

Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer

Por Halabi, Susan, Vogelzang, Nicholas J., Ou, San-San, Owzar, Kouros, Archer, Laura, Small, Eric J.
Publicado em 2009

Novel therapies for metastatic renal cell carcinoma: Efforts to expand beyond the VEGF/mTOR signaling paradigm

Por Pal, Sumanta Kumar, Williams, Stephen, Josephson, David Y., Carmichael, Courtney, Vogelzang, Nicholas J., Quinn, David I.
Publicado em 2012

Chemotherapy following radium‐223 dichloride treatment in ALSYMPCA

Por Sartor, Oliver, Hoskin, Peter, Coleman, Robert E., Nilsson, Sten, Vogelzang, Nicholas J., Petrenciuc, Oana, Staudacher, Karin, Thuresson, Marcus, Parker, Christopher
Publicado no Prostate (2016)

CKD-EPI and Cockcroft-Gault Equations Identify Similar Candidates for Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer

Por Pal, Sumanta K., Ruel, Nora, Villegas, Sergio, Chang, Mark, DeWalt, Kara, Wilson, Timothy G., Vogelzang, Nicholas J., Yuh, Bertram E.
Publicado em 2014

Sequential Therapy in Metastatic Renal Cell Carcinoma

Por Hirsch, Bradford R., Burke, John M., Agrawal, Manish, Hauke, Ralph J., Hutson, Thomas E., Doshi, Gury, Fleming, Mark T., Vogelzang, Nicholas J.
Publicado no J Kidney Cancer VHL (2016)

A PHASE II STUDY OF ESTRAMUSTINE, DOCETAXEL, AND BEVACIZUMAB IN MEN WITH CASTRATE RESISTANT PROSTATE CANCER: RESULTS OF CANCER AND LEUKEMIA GROUP B (CALGB) 90006

Por Picus, Joel, Halabi, Susan, Kelly, W. Kevin, Vogelzang, Nicholas J., Whang, Young E., Kaplan, Ellen B., Stadler, Walter M., Small, Eric J.
Publicado em 2010

TUMOR VOLUME CHANGES ON 1.5 TESLA ENDORECTAL MRI DURING NEOADJUVANT ANDROGEN SUPPRESSION THERAPY FOR HIGHER-RISK PROSTATE CANCER AND RECURRENCE IN MEN TREATED USING RADIATION THERA...

Por D'Amico, Anthony V., Halabi, Susan, Tempany, Clare, Titelbaum, David, Philips, George K., Loffredo, Marian, McMahon, Elizabeth, Sanford, Ben, Vogelzang, Nicholas J., Small, Eric J.
Publicado em 2007

Cooperative group trials – Southwest Oncology Group (SWOG) innovations in advanced prostate cancer

Por Dorff, Tanya B., Tangen, Cathy M., Crawford, E. David, Petrylak, Daniel P., Higano, Celestia S., Raghavan, Derek, Quinn, David I., Vogelzang, Nicholas J., Thompson, Ian M., Hussain, Maha H.A.
Publicado em 2009

Quality of pathologic response and surgery correlate with survival for completely resected bladder cancer following neoadjuvant chemotherapy

Por Sonpavde, Guru, Goldman, Bryan H., Speights, V.O., Lerner, Seth P., Wood, David P., Vogelzang, Nicholas J., Trump, Donald L., Natale, Ronald B., Grossman, H. Barton, Crawford, E. David
Publicado em 2009

Phase II Evaluation of Early Oral Estramustine, Oral Etoposide and Intravenous Paclitaxel in Combination with Hormone Therapy in Patients with High-Risk Metastatic Adenocarcinoma o...

Por Smith, David C., Tangen, Cathy M., Hussain, Maha H.A., Van Veldhuizen, Peter J., Harrer, Grant W., Stuart, Robert K., Mills, Glenn M., Vogelzang, Nicholas J., Thompson, Ian M.
Publicado em 2011

A Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid Tumors

Por Weber, Jeffrey S., Vogelzang, Nicholas J., Ernstoff, Marc S., Goodman, Oscar B., Cranmer, Lee D., Marshall, John L., Miles, Sabrina, Rosario, Dar, Diamond, David C., Qiu, Zhiyong, Obrocea, Mihail, Bot, Adrian
Publicado em 2011

Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Can...

Por Kelly, William Kevin, Halabi, Susan, Carducci, Michael, George, Daniel, Mahoney, John F., Stadler, Walter M., Morris, Michael, Kantoff, Philip, Monk, J. Paul, Kaplan, Ellen, Vogelzang, Nicholas J., Small, Eric J.
Publicado em 2012

Two Phase II Trials of the Novel Akt Inhibitor Perifosine in Patients with Advanced Renal Cell Carcinoma Following Progression on VEGF-Targeted Therapy

Por Cho, Daniel C., Hutson, Thomas E., Samlowski, Wolfram, Sportelli, Peter, Somer, Brad, Richards, Paul, Sosman, Jeffrey A., Puzanov, Igor, Michaelson, M. Dror, Flaherty, Keith T., Figlin, Robert A, Vogelzang, Nicholas J
Publicado em 2012

PD-1 and PD-L1 Expression in Renal Cell Carcinoma With Sarcomatoid Differentiation

Por Joseph, Richard W., Millis, Sherri Z., Carballido, Estrella M., Bryant, David, Gatalica, Zoran, Reddy, Sandeep, Bryce, Alan H., Vogelzang, Nicholas J., Stanton, Melissa L., Castle, Erik P., Ho, Thai H.
Publicado no Cancer Immunol Res (2015)

Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma

Por Krug, Lee M., Pass, Harvey I., Rusch, Valerie W., Kindler, Hedy L., Sugarbaker, David J., Rosenzweig, Kenneth E., Flores, Raja, Friedberg, Joseph S., Pisters, Katherine, Monberg, Matthew, Obasaju, Coleman K., Vogelzang, Nicholas J.
Publicado em 2009

Serum Biomarkers of Bone Metabolism in Castration-Resistant Prostate Cancer Patients With Skeletal Metastases: Results From SWOG 0421

Por Lara, Primo N., Ely, Benjamin, Quinn, David I., Mack, Philip C., Tangen, Catherine, Gertz, Erik, Twardowski, Przemyslaw W., Goldkorn, Amir, Hussain, Maha, Vogelzang, Nicholas J., Thompson, Ian M., Van Loan, Marta D.
Publicado em 2014

A Phase 1, Open–label Study of Trebananib Combined With Sorafenib or Sunitinib in Patients With Advanced Renal Cell Carcinoma

Por Hong, David S., Gordon, Michael S., Samlowski, Wolfram E., Kurzrock, Razelle, Tannir, Nizar, Friedland, David, Mendelson, David S., Vogelzang, Nicholas J., Rasmussen, Erik, Wu, Benjamin M., Bass, Michael B., Zhong, Zhandong D., Friberg, Gregory, Appleman, Leonard J.
Publicado no Clin Genitourin Cancer (2013)